ConjuStar Raises RMB100 Million to Advance X-Drug Conjugates Pipeline
ConjuStar, a specialist in X-Drug conjugates (XDCs) based in Tianjin, has reportedly raised RMB100 million...
ConjuStar
ConjuStar Completes $15 Million Pre-A+ Financing Round
ConjuStar, a clinical-stage biotechnology company based in Tianjin, China, has announced the completion of a...
ConjuStar Peptide-Drug Conjugate Angel Financing
Tianjin-based ConjuStar, a peptide-drug conjugate (PDC) developer incubated by Fosun Pharma and Wuxi Apptec, has...